How do we handle one-time capital injections or major process automation investments during a buy-side Quality of Earnings (QofE) review so they are not classified as normal operating expenses?

Question

Tyler Smith · Accepted Answer

During a buy-side Quality of Earnings audit, the buy-side analysts will scrutinize every expense to find reasons to normalize your EBITDA downward. Major investments in operational automation or one-time consulting fees to build out your scalable infrastructure are often flagged as standard operating expenses. This artificially depresses your historical earnings and your valuation multiple. To defend your numbers, you must present these expenditures as non-recurring capital investments. Prepare a clear, documented ledger of these specific expenses before the audit begins. Show how these investments directly led to permanent operational efficiency gains and lower ongoing labor costs. Use your V/TO® and historical quarterly Rocks to prove these were finite, strategic initiatives rather than recurring operational overhead. If you can show that the work is complete and the cash outlay has stopped while the efficiency gains remain, a sophisticated buyer must accept these as EBITDA add-backs. This maintains your true run-rate profitability. Do not wait for the buy-side firm to find these. Work with your fractional CFO to identify every dollar spent on these transitional projects over the last three years and package them as pro-forma adjustments. This ensures your high-margin operations are valued on their actual forward-looking earning capacity rather than historical setup costs.